Montana § 50-32-232 - Specific Dangerous Drugs Included In Schedule V
Full text of Montana Montana Code Annotated § 50-32-232 — Specific Dangerous Drugs Included In Schedule V, with citation guidance and answers to common questions.
§ 50-32-232. Specific Dangerous Drugs Included In Schedule V
Specific dangerous drugs included in Schedule V. Schedule V consists of the drugs and other substances, by whatever official, common, usual, chemical, or brand name designated, listed in this section. (1) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following is a narcotic drug, including its salts, calculated as the free anhydrous base or alkaloid in limited quantities as set forth in subsections (1)(a) through (1)(f), which include one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone: (a) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams; (b) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams; (c) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams; (d) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; (e) not more than 100 milligrams of opium per 100 milliliters or per 100 grams; and (f) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit. (2) Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of pyrovalerone is a stimulant having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers. (3) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances is a depressant having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers: (a) lacosamide, also known as (R)-2-acetoamido-N-benzyl-3-methoxy-propionamide or vimpat; (b) pregabalin, also known as (S)-3-(aminomethyl)-5-methylhexanoic acid or lyrica; and (c) gabapentin, also known as 1-(aminomethyl)cyclohexaneacetic acid. (4) Anticonvulsant substances include the following: (a) ezogabine; (b) brivaracetam; (c) cenobamate; and (d) ganaxalone. (5) Antimigraine substances including lasmiditan.
Source: official Montana text · Last verified 2026-08-27
Frequently Asked Questions About Montana § 50-32-232
What does Montana Code Annotated § 50-32-232 cover?
Section 50-32-232 ("Specific Dangerous Drugs Included In Schedule V") is part of the Montana Code Annotated, the codified statutory law of Montana. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.
How do I cite Montana § 50-32-232?
A common citation format is "Montana Code Annotated § 50-32-232" (Montana). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.
Is this the official text of Montana law?
No. This page is for research and education and may not include the most recent amendments. For official current law, check the Montana official source linked on this page or consult a licensed Montana attorney.
How does Montana § 50-32-232 apply to my situation?
Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in Montana can advise on how this section applies to you. Contact your state or local bar association for a referral.
Sources & Verification
Not legal advice. Verify against the official source and consult a licensed attorney in Montana.